Sequential Therapy for Helicobacter pylori Infection in Korea: Systematic Review and Meta-Analysis
- PMID: 24073312
- PMCID: PMC3782669
- DOI: 10.5009/gnl.2013.7.5.546
Sequential Therapy for Helicobacter pylori Infection in Korea: Systematic Review and Meta-Analysis
Abstract
Background/aims: Sequential therapy (ST) for Helicobacter pylori infection in countries other than Korea has shown higher eradication rates than triple therapy (TT). The aim of this study was to evaluate the efficacy of ST in Korea by performing a meta-analysis.
Methods: We performed a comprehensive literature search on the efficacy of ST as a first-line therapy. The odds ratios (ORs) of eradicating H. pylori infection after ST compared with TT were pooled. Pooled estimates of the eradication rates of ST and TT were also calculated.
Results: A total of six studies provided data on 1,759 adult patients. The ORs for the intention to treat (ITT) and the per-protocol (PP) eradication rate were 1.761 (95% confidence interval [CI], 1.403 to 2.209) and 1.966 (95% CI, 1.489 to 2.595). Pooled estimates of the ITT and PP eradication rate were 79.4% (95% CI, 76.3% to 82.2%) and 86.4% (95% CI, 83.5% to 88.8%), respectively, for the ST group, and 68.2% (95% CI, 62.1% to 73.8%) and 78.9% (95% CI, 68.9% to 81.7%), respectively, for the TT group.
Conclusions: Although ST presented a higher eradication rate than TT in Korea, the pooled eradication rates were lower than expected. Further studies are needed to validate ST as a first-line treatment for H. pylori in Korea.
Keywords: Eradication; Helicobacter pylori; Meta-analysis.
Conflict of interest statement
No potential conflict of interest relevant to this article was reported.
Figures





Similar articles
-
Ten-Day Concomitant, 10-Day Sequential, and 7-Day Triple Therapy as First-Line Treatment for Helicobacter pylori Infection: A Nationwide Randomized Trial in Korea.Gut Liver. 2019 Sep 15;13(5):531-540. doi: 10.5009/gnl19136. Gut Liver. 2019. PMID: 31505907 Free PMC article. Clinical Trial.
-
Sequential or concomitant therapy for eradication of Helicobacter pylori infection: A systematic review and meta-analysis.J Gastroenterol Hepatol. 2015 Sep;30(9):1338-45. doi: 10.1111/jgh.12984. J Gastroenterol Hepatol. 2015. PMID: 25867718
-
Concomitant or Sequential Therapy as the First-line Therapy for Eradication of Helicobacter pylori Infection in Korea: A Systematic Review and Meta-analysis.Korean J Gastroenterol. 2018 Jan 25;71(1):31-37. doi: 10.4166/kjg.2018.71.1.31. Korean J Gastroenterol. 2018. PMID: 29361811
-
Meta-analysis: Sequential therapy is superior to conventional therapy for Helicobacter pylori infection in Korea.Korean J Gastroenterol. 2013 Nov;62(5):267-71. doi: 10.4166/kjg.2013.62.5.267. Korean J Gastroenterol. 2013. PMID: 24262591
-
Sequential Therapy versus Triple Therapy for the First Line Treatment of Helicobacter pylori in Korea: A Nationwide Randomized Trial.Gut Liver. 2016 Jul 15;10(4):556-61. doi: 10.5009/gnl15470. Gut Liver. 2016. PMID: 27114421 Free PMC article. Clinical Trial.
Cited by
-
Ten-Day Concomitant, 10-Day Sequential, and 7-Day Triple Therapy as First-Line Treatment for Helicobacter pylori Infection: A Nationwide Randomized Trial in Korea.Gut Liver. 2019 Sep 15;13(5):531-540. doi: 10.5009/gnl19136. Gut Liver. 2019. PMID: 31505907 Free PMC article. Clinical Trial.
-
Role of Antimicrobial Susceptibility Testing before First-Line Treatment Containing Clarithromycin for Helicobacter pylori Eradication in the Clinical Setting.Antibiotics (Basel). 2021 Feb 21;10(2):214. doi: 10.3390/antibiotics10020214. Antibiotics (Basel). 2021. PMID: 33669969 Free PMC article.
-
The impact of bismuth addition to sequential treatment on Helicobacter pylori eradication: A pilot study.Bosn J Basic Med Sci. 2015 Oct 25;15(4):50-4. doi: 10.17305/bjbms.2015.573. Bosn J Basic Med Sci. 2015. PMID: 26614852 Free PMC article.
-
Nonbismuth concomitant quadruple therapy for Helicobacter pylori eradication in Chinese regions: A meta-analysis of randomized controlled trials.World J Gastroenterol. 2016 Jun 21;22(23):5445-53. doi: 10.3748/wjg.v22.i23.5445. World J Gastroenterol. 2016. PMID: 27340362 Free PMC article.
-
Concomitant, sequential, and 7-day triple therapy in first-line treatment of Helicobacter pylori infection in Korea: study protocol for a randomized controlled trial.Trials. 2017 Nov 17;18(1):549. doi: 10.1186/s13063-017-2281-0. Trials. 2017. PMID: 29149904 Free PMC article. Clinical Trial.
References
-
- Vakil N, Megraud F. Eradication therapy for Helicobacter pylori. Gastroenterology. 2007;133:985–1001. - PubMed
-
- Zullo A, Vaira D, Vakil N, et al. High eradication rates of Helicobacter pylori with a new sequential treatment. Aliment Pharmacol Ther. 2003;17:719–726. - PubMed
-
- Gatta L, Vakil N, Leandro G, Di Mario F, Vaira D. Sequential therapy or triple therapy for Helicobacter pylori infection: systematic review and meta-analysis of randomized controlled trials in adults and children. Am J Gastroenterol. 2009;104:3069–3079. - PubMed
-
- Tong JL, Ran ZH, Shen J, Xiao SD. Sequential therapy vs. standard triple therapies for Helicobacter pylori infection: a meta-analysis. J Clin Pharm Ther. 2009;34:41–53. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous